25D-NBOMe

25D-NBOMe directly inhibits hERG potassium channels (Yoon 2019), prolonging the QT interval. In individuals with congenital or acquired long QT syndrome, this creates direct risk of torsades de pointes and fatal ventricular arrhythmia.

sotalol, amiodarone, haloperidol, ziprasidone, erythromycin, fluoroquinolones

Co-administration with antiarrhythmics, certain antipsychotics, macrolide antibiotics, or fluoroquinolones creates additive QT prolongation risk via shared hERG channel inhibition mechanism.

25D-NBOMe produces sympathomimetic effects — elevated heart rate, blood pressure, and vasoconstriction — that place additional strain on a compromised cardiovascular system.

NBOMe compounds are documented to lower seizure threshold, particularly at higher doses. Individuals with pre-existing seizure disorders face elevated risk of seizure induction.

Serotonergic psychedelics as a class carry documented risk of precipitating psychotic episodes in individuals with a personal or family history of psychotic disorders. NBOMe-induced psychotic symptoms including delusions and disorganized behavior are documented in class literature.

25D-NBOMe metabolism is predicted to rely on CYP2C9, CYP2C19, CYP1A2, and CYP3A4 (inferred from 25B/25C-NBOMe data, Caspar 2017). Hepatic impairment could reduce metabolic clearance and increase exposure duration and intensity.

Low potassium or magnesium levels increase the cardiac risk from hERG channel inhibition, making drug-induced QT prolongation more likely to progress to torsades de pointes.

MAOIs, SSRIs, SNRIs, tramadol

As a potent 5-HT2A full agonist, 25D-NBOMe combined with MAOIs, SSRIs, SNRIs, or tramadol presents risk of serotonin syndrome — a potentially life-threatening condition characterized by hyperthermia, muscle rigidity, and autonomic instability.

Lithium combined with serotonergic psychedelics carries documented seizure risk. This interaction is established in the broader psychedelic class literature and applies to 25D-NBOMe by pharmacological extrapolation.